A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation

Authors
Publication date
1 January 2005
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    IRIS Università Politecnica delle Marche

    redirect
    oaioai:iris.univpm.it:11566/52068
    Last time updated on 11/04/2020